Rat monoclonal antibodies against bone sialoprotein II inhibit tumor growth and osteolytic lesions in nude rats induced by MDA-MB-231 breast cancer cells.
Zepp
M
M
Txicology and Chemotherapy Unit, DKFZ, Heidelberg, Germany. m.zepp@dkfz.de
Armbruster
F P
FP
Berger
M R
MR
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000517:prevention & control / Q000556:secondary*; D005260:Female; D006801:Humans; D058574:Integrin-Binding Sialoprotein; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy* / Q000473:pathology; D010014:Osteolysis; D051381:Rats; D011923:Rats, Nude; D012795:Sialoglycoproteins / Q000037:antagonists & inhibitors*; D023041:Xenograft Model Antitumor Assays
D000911:Antibodies, Monoclonal; C546871:IBSP protein, human; C546873:Ibsp protein, rat; D058574:Integrin-Binding Sialoprotein; D012795:Sialoglycoproteins